Loading

Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit

BOCA RATON, Fla.June 12, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare, will participate in a panel discussion, titled “New Treatments for Rare/Orphan Diseases and Oncologic Conditions,” at the Cantor Fitzgerald Dermatology & Aesthetics Summit on Tuesday, June 19 at 2:00 pm ET in New York.  The Summit is being held at the Westin Grand Central Hotel.

Read the full press release here.

Share to:

Contact Us

Fill out the form below to find out more!